Pms17 Cost Effectiveness Analysis of Upadacitinib and Methotrexate for Patients With Methotrexate-Resistant Rheumatoid Arthritis

Abstract

men, 4.8% in women) were the main cost drivers, while all other forms of medical care amounted to 5.1% in men and 5.8% in women. Annual health care treatment cost per patient was 15,188 HUF (56 USD/48 EUR) in men and 10,266 HUF (38 USD/22 EUR) in women. Conclusions: Outpatient care was the major cost driver. There was a difference in major cost drivers between men and women. Average, annual health insurance costs per patient was 48% higher in men.